These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15814443)

  • 1. Cognitive impairment in primary and secondary progressive multiple sclerosis.
    Wachowius U; Talley M; Silver N; Heinze HJ; Sailer M
    J Clin Exp Neuropsychol; 2005 Jan; 27(1):65-77. PubMed ID: 15814443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuropsychology of primary progressive multiple sclerosis].
    Paes RA; Alvarenga RM; Vasconcelos CC; Negreiros MA; Landeira-Fernández J
    Rev Neurol; 2009 Oct 1-15; 49(7):343-8. PubMed ID: 19774527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study.
    Ukkonen M; Vahvelainen T; Hämäläinen P; Dastidar P; Elovaara I
    Mult Scler; 2009 Sep; 15(9):1055-61. PubMed ID: 19556313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis.
    Tur C; Penny S; Khaleeli Z; Altmann DR; Cipolotti L; Ron M; Thompson AJ; Ciccarelli O
    Mult Scler; 2011 Nov; 17(11):1324-32. PubMed ID: 21803874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Compromise of the cognitive functions in progressive secondary multiple sclerosis].
    Andreu-Català M; Pascual-Lozano AM; Bueno-Cayo A; Boscá-Blasco I; Coret-Ferrer F; Casanova-Estruch B
    Rev Neurol; 2008 Jun 1-15; 46(11):664-6. PubMed ID: 18509824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters.
    Denney DR; Lynch SG; Parmenter BA
    J Neurol Sci; 2008 Apr; 267(1-2):129-36. PubMed ID: 17976653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis.
    Gaudino EA; Chiaravalloti ND; DeLuca J; Diamond BJ
    Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan; 14(1):32-44. PubMed ID: 11234907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment and decline in different MS subtypes.
    Huijbregts SC; Kalkers NF; de Sonneville LM; de Groot V; Polman CH
    J Neurol Sci; 2006 Jun; 245(1-2):187-94. PubMed ID: 16643951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
    Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
    Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Information processing efficiency in patients with multiple sclerosis.
    Archibald CJ; Fisk JD
    J Clin Exp Neuropsychol; 2000 Oct; 22(5):686-701. PubMed ID: 11094403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of decision-making capacity in primary and secondary progressive multiple sclerosis].
    García-Molina A; Enseñat-Cantallops A; Sánchez-Carrión R; Roig-Rovira T
    Neurologia; 2009 Mar; 24(2):94-7. PubMed ID: 19322686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive reserve in secondary progressive multiple sclerosis.
    Sumowski JF; Chiaravalloti N; Leavitt VM; Deluca J
    Mult Scler; 2012 Oct; 18(10):1454-8. PubMed ID: 22389412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.
    Strober L; Englert J; Munschauer F; Weinstock-Guttman B; Rao S; Benedict RH
    Mult Scler; 2009 Sep; 15(9):1077-84. PubMed ID: 19556311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Default-mode network dysfunction and cognitive impairment in progressive MS.
    Rocca MA; Valsasina P; Absinta M; Riccitelli G; Rodegher ME; Misci P; Rossi P; Falini A; Comi G; Filippi M
    Neurology; 2010 Apr; 74(16):1252-9. PubMed ID: 20404306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
    Dackovic J; Pekmezovic T; Mesaros S; Dujmovic I; Stojsavljevic N; Martinovic V; Drulovic J
    Neurol Sci; 2016 Sep; 37(9):1475-81. PubMed ID: 27207679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive changes in spinocerebellar ataxia type 2.
    Valis M; Masopust J; Bažant J; Ríhová Z; Kalnická D; Urban A; Zumrová A; Hort J
    Neuro Endocrinol Lett; 2011; 32(3):354-9. PubMed ID: 21712788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS.
    Huijbregts SC; Kalkers NF; de Sonneville LM; de Groot V; Reuling IE; Polman CH
    Neurology; 2004 Jul; 63(2):335-9. PubMed ID: 15277630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.